Skip to main content
Premium Trial:

Request an Annual Quote

Oklahoma Group Puts $900K into Local Genomics Research

NEW YORK (GenomeWeb News) - The Oklahoma Center for the Advancement of Science and Technology has granted a total of $900,000 to three Oklahoma-based genomics research projects.
The money was granted under the state technology development group’s Oklahoma Applied Research Support program, which is administering a total of $1.9 million to a number of technological programs based in the state, Bradley Sutherlin, OCAST’s contracts compliance officer, told GenomeWeb Daily News.
OCAST granted Riley Genomics $300,000 over three years that the company will use to develop a rheumatic blood test based on gene expression profiling.
Another recipient, Intergenetics, will use $300,000 over two years to develop multiplex assays to study DNA sequencing variations that could be used to help predict cancer risk and outcomes.
OCAST also will grant $300,000 over three years to Liyou Wu at the Institute of Environmental Genomics to develop microarray technology.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.